Maternal active and passive smoking and hypertensive disorders of pregnancy: Risk with trimester-specific exposures

Epidemiology

Volumn 24, Issue 3, 2013, Pages 379-386

  Engel, Stephanie M ^a   Scher, Erica ^b   Wallenstein, Sylvan ^b   Savitz, David A ^c   Alsaker, Elin R ^d   Trogstad, Lill ^d   Magnus, Per ^d  

^a IL   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c BROWN UNIVERSITY   (United States)

^d NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MATERNAL SMOKING; PASSIVE SMOKING; PREECLAMPSIA; PREGNANCY OUTCOME; PRENATAL EXPOSURE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SECOND TRIMESTER PREGNANCY; SMOKING CESSATION; THIRD TRIMESTER PREGNANCY;

ADULT; COHORT STUDIES; FEMALE; HEALTH SURVEYS; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; MATERNAL EXPOSURE; MODELS, STATISTICAL; NORWAY; ODDS RATIO; PREGNANCY; PREGNANCY TRIMESTERS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; SMOKING; TOBACCO SMOKE POLLUTION;

EID: 84876296390     PISSN: 10443983     EISSN: 15315487     Source Type: Journal    
DOI: 10.1097/EDE.0b013e3182873a73     Document Type: Article

References (47)

1. Salihu HM, Wilson RE. Epidemiology of prenatal smoking and perinatal outcomes. Early Hum Dev. 2007;83:713-720.
2. Sibai BM, Hauth J, Caritis S, et al. Hypertensive disorders in twin versus singleton gestations. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol. 2000;182:938-942.
3. Conde-Agudelo A, Althabe F, Belizán JM, Kafury-Goeta AC. Cigarette smoking during pregnancy and risk of preeclampsia: a systematic review. Am J Obstet Gynecol. 1999;181:1026-1035.
4. Engel SM, Janevic TM, Stein CR, Savitz DA. Maternal smoking, pre-eclampsia, and infant health outcomes in New York City, 1995-2003. Am J Epidemiol. 2009;169:33-40.
5. Wikström AK, Stephansson O, Cnattingius S. Tobacco use during pregnancy and preeclampsia risk: effects of cigarette smoking and snuff. Hypertension. 2010;55:1254-1259.
6. Wang X, Zuckerman B, Pearson C, et al. Maternal cigarette smoking, metabolic gene polymorphism, and infant birth weight. JAMA. 2002;287:195-202.
7. Jaddoe V W, Troe EJ, Hofman A, et al. Active and passive maternal smoking during pregnancy and the risks of low birthweight and preterm birth: the Generation R Study. Paediatr Perinat Epidemiol. 2008;22:162-171.
8. Reeves S, Bernstein I. Effects of maternal tobacco-smoke exposure on fetal growth and neonatal size. Expert Rev Obstet Gynecol. 2008;3:719-730.
9. Haskins A, Mukhopadhyay S, Pekow P, et al. Smoking and risk of pre-term birth among predominantly Puerto Rican women. Ann Epidemiol. 2008;18:440-446.
10. Tsai HJ, Liu X, Mestan K, et al. Maternal cigarette smoking, metabolic gene polymorphisms, and preterm delivery: new insights on GxE interactions and pathogenic pathways. Hum Genet. 2008;123:359-369.
11. Chen H, Huang X, Guo X, et al. Smoking duration, intensity, and risk of Parkinson disease. Neurology. 2010;74:878-884.
12. Nilsen RM, Vollset SE, Gjessing HK, et al. Self-selection and bias in a large prospective pregnancy cohort in Norway. Paediatr Perinat Epidemiol. 2009;23:597-608.
13. Magnus P, Irgens LM, Haug K, Nystad W, Skjaerven R, Stoltenberg C; MoBa Study Group. Cohort profle: the Norwegian Mother and Child Cohort Study (MoBa). Int J Epidemiol. 2006;35:1146-1150.
14. Irgens LM. The Medical Birth Registry of Norway. Epidemiological research and surveillance throughout 30 years. Acta Obstet Gynecol Scand. 2000;79:435-439.
15. Bakker R, Steegers EA, Mackenbach J P, Hofman A, Jaddoe V W. Maternal smoking and blood pressure in different trimesters of pregnancy: the Generation R study. J Hypertens. 2010;28:2210-2218.
16. Xiong X, Zhang J, Fraser WD. Quitting smoking during early versus late pregnancy: the risk of preeclampsia and adverse birth outcomes. J Obstet Gynaecol Can. 2009;31:702-707.
17. Marcoux S, Brisson J, Fabia J. The effect of cigarette smoking on the risk of preeclampsia and gestational hypertension. Am J Epidemiol. 1989;130:950-957.
18. England LJ, Levine RJ, Qian C, et al. Smoking before pregnancy and risk of gestational hypertension and preeclampsia. Am J Obstet Gynecol. 2002;186:1035-1040.
19. Zhang J, Klebanoff MA, Levine RJ, Puri M, Moyer P. The puzzling association between smoking and hypertension during pregnancy. Am J Ob-stet Gynecol. 1999;181:1407-1413.
20. Sibai BM, Gordon T, Thom E, et al. Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol. 1995;172(2 Pt 1): 642-648.
21. Obel C, Linnet KM, Henriksen TB, et al. Smoking during pregnancy and hyperactivity-inattention in the offspring-comparing results from three Nordic cohorts. Int J Epidemiol. 2009;38:698-705.
22. Braun JM, Kahn RS, Froehlich T, Auinger P, Lanphear B P. Exposures to environmental toxicants and attention defcit hyperactivity disorder in U.S. children. Environ Health Perspect. 2006;114:1904-1909.
23. Schneider T, Ilott N, Brolese G, Bizarro L, Asherson PJ, Stolerman I P. Prenatal exposure to nicotine impairs performance of the 5-choice serial reaction time task in adult rats. Neuropsychopharmacology. 2011;36:1114-1125.
24. Garcia-Rill E, Buchanan R, McKeon K, Skinner RD, Wallace T. Smoking during pregnancy: postnatal effects on arousal and attentional brain systems. Neurotoxicology. 2007;28:915-923.
25. Obel C, Olsen J, Henriksen TB, et al. Is maternal smoking during pregnancy a risk factor for hyperkinetic disorder?-Findings from a sibling design. Int J Epidemiol. 2011;40:338-345.
26. Ball S W, Gilman SE, Mick E, et al. Revisiting the association between maternal smoking during pregnancy and ADHD. J Psychiatr Res. 2010;44:1058-1062.
27. Redman C W, Sargent IL. Latest advances in understanding preeclampsia. Science. 2005;308:1592-1594.
28. Lain KY, Roberts JM. Contemporary concepts of the pathogenesis and management of preeclampsia. JAMA. 2002;287:3183-3186.
29. Sargent IL, Germain SJ, Sacks G P, Kumar S, Redman C W. Trophoblast deportation and the maternal infammatory response in pre-eclampsia. J Reprod Immunol. 2003;59:153-160.
30. Tjoa ML, Levine RJ, Karumanchi SA. Angiogenic factors and preeclamp-sia. Front Biosci. 2007;12:2395-2402.
31. Maynard SE, Min J Y, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111: 649-658.
32. Venkatesha S, Toporsian M, Lam C, et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med. 2006;12:642-649.
33. Otterbein LE, Bach FH, Alam J, et al. Carbon monoxide has anti-infam-matory effects involving the mitogen-activated protein kinase pathway. Nat Med. 2000;6:422-428.
34. Zhang F, Kaide JI, Rodriguez-Mulero F, Abraham NG, Nasjletti A. Vaso-regulatory function of the heme-heme oxygenase-carbon monoxide system. Am J Hypertens. 2001;14(6 Pt 2):62S-67S.
35. Fujita T, Toda K, Karimova A, et al. Paradoxical rescue from ischemic lung injury by inhaled carbon monoxide driven by derepression of fbri-nolysis. Nat Med. 2001;7:598-604.
36. Brouard S, Otterbein LE, Anrather J, et al. Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J Exp Med. 2000;192:1015-1026.
37. Liu XM, Chapman GB, Peyton KJ, Schafer AI, Durante W. Carbon monoxide inhibits apoptosis in vascular smooth muscle cells. Cardiovasc Res. 2002;55:396-405.
38. Wang X, Wang Y, Kim HP, Nakahira K, Ryter SW, Choi AM. Carbon monoxide protects against hyperoxia-induced endothelial cell apop-tosis by inhibiting reactive oxygen species formation. J Biol Chem. 2007;282:1718-1726.
39. Powers RW, Roberts JM, Cooper KM, et al. Maternal serum soluble fms-like tyrosine kinase 1 concentrations are not increased in early pregnancy and decrease more slowly postpartum in women who develop preeclamp-sia. Am J Obstet Gynecol. 2005;193:185-191.
40. Cudmore M, Ahmad S, Al-Ani B, et al. Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1. Circulation. 2007;115:1789-1797.
41. Ros HS, Cnattingius S, Lipworth L. Comparison of risk factors for pre-eclampsia and gestational hypertension in a population-based cohort study. Am J Epidemiol. 1998;147:1062-1070.
42. Wolf M, Shah A, Lam C, et al. Circulating levels of the antiangiogenic marker sFLT-1 are increased in frst versus second pregnancies. Am J Ob-stet Gynecol. 2005;193:16-22.
43. Bdolah Y, Lam C, Rajakumar A, et al. Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia? Am J Obstet Gynecol. 2008;198:428.e1-428.e6.
44. Kahn SR, Almeida ND, McNamara H, et al. Smoking in preeclamptic women is associated with higher birthweight for gestational age and lower soluble fms-like tyrosine kinase-1 levels: a nested case control study. BMC Pregnancy Childbirth. 2011;11:91.
45. Jeyabalan A, Powers RW, Durica AR, Harger GF, Roberts JM, Ness RB. Cigarette smoke exposure and angiogenic factors in pregnancy and pre-eclampsia. Am J Hypertens. 2008;21:943-947.
46. Karumanchi SA, Levine RJ. How does smoking reduce the risk of pre-eclampsia? Hypertension. 2010;55:1100-1101.
47. Pickett KE, Rathouz PJ, Kasza K, Wakschlag LS, Wright R. Self-reported smoking, cotinine levels, and patterns of smoking in pregnancy. Paediatr Perinat Epidemiol. 2005;19:368-376.